Last reviewed · How we verify

NCT04374318

Comparison Between Intrathecal and Intravenous Dexmedetomidine

Completed NA Last updated 7 May 2020
What this trial tests

NA trial testing Dexmedetomidine in Postoperative Analgesia in 70 participants. Completed in 30 March 2020.

Timeline
1 March 2019
Primary endpoint
30 October 2019
30 March 2020

Quick facts

Lead sponsorSuez Canal University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposetreatment
Enrollment70
Start date1 March 2019
Primary completion30 October 2019
Estimated completion30 March 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Suez Canal University

Who can join

Adults 18 to 65, any sex, with Postoperative Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, randomized, comparative controlled clinical trial, aiming to compare the use of intrathecal dexmedetomidine by intravenous dexmedetomidine in concern of the first request to analgesia. The secondary end-points were the total postoperative analgesic consumption as well as the VAS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dexmedetomidine

Trials testing the same drug.

Other recruiting trials for Postoperative Analgesia

Currently open trials in the same condition.

Other Suez Canal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04374318.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing